Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Non-interventional, Multi-center Study to Evaluate Efficacy and Tolerability of High Dose Rosuvastatin in High Risk Patients After Titration

NCT00526721 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00526721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00526721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Non-interventional, Multi-center Study to Evaluate Efficacy and Tolerability of High Dose Rosuvastatin in High Risk Patients After Titration
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2007
Completion date
April 30, 2008
Enrollment
1,482 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia